Toltrazuril for Ox: Coccidiosis Uses & Safety

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Toltrazuril is an antiprotozoal medication used against coccidia, especially Eimeria species that cause bovine coccidiosis. It is not an antibiotic and it does not treat worms. Instead, it targets the parasite stages that damage the lining of the intestine.

In calves and young cattle, coccidiosis can cause diarrhea, straining, dehydration, poor growth, and sometimes blood in the stool. Merck Veterinary Manual lists toltrazuril as one of the oral drugs used to decrease oocyst production in affected calves and others in the group. That matters because lowering parasite shedding can help reduce contamination pressure in the environment.

One important point for U.S. producers and pet parents with food animals: there is no FDA-approved toltrazuril product for cattle in the United States as of March 16, 2026. In other countries, labeled cattle products exist, but U.S. use requires careful veterinary oversight and food-safety planning. Your vet may discuss whether another labeled option is more appropriate for your animal, production class, and residue-risk situation.

Toltrazuril is used for bovine coccidiosis, a parasitic intestinal disease seen most often in calves after the first few weeks of life and up to about a year of age. Disease risk rises with crowding, wet bedding, contaminated feed or water, transport stress, weaning, and other management changes.

Your vet may consider it when calves have diarrhea, tenesmus, poor thrift, rough hair coat, or confirmed fecal evidence of Eimeria infection. It is often discussed for group-level control too, because calves sharing a pen are commonly exposed even if only a few are visibly sick.

Toltrazuril does not fix dehydration, intestinal damage, or secondary bacterial disease by itself. Supportive care still matters. Depending on the case, your vet may pair parasite treatment with oral or IV fluids, nursing care, improved bedding hygiene, and isolation of clinically affected calves.

Because coccidiosis can look like salmonellosis, coronavirus, BVD-related disease, dietary upset, or other causes of calf diarrhea, your vet may recommend fecal testing or herd-level diagnostics before choosing a treatment plan.

Published veterinary references and cattle product labels outside the U.S. commonly describe toltrazuril as a single oral dose for calves. Merck Veterinary Manual lists 15 mg/kg by mouth once for affected calves and exposed group-mates. Some non-U.S. labels also describe 20 mg/kg by mouth once depending on the formulation, so the exact volume in milliliters depends on the concentration your vet is using.

That is why you should never calculate the dose from internet advice alone. A 5% oral suspension, a 2.5% solution, and a compounded product all deliver different amounts per milliliter. Your vet will base the dose on the animal's current body weight, the product concentration, treatment goal, and food-animal status.

In practical terms, accurate dosing means weighing or closely estimating body weight, giving the medication by mouth as directed, and treating at the right stage of disease. Once calves are severely dehydrated or have major intestinal injury, response can be less predictable even when the parasite treatment is appropriate.

Ask your vet specifically about meat and milk withholding instructions. In countries where cattle toltrazuril products are labeled, withdrawal periods can be long, and some labels state the drug is not authorized for animals producing milk for human consumption. In the U.S., residue avoidance planning is especially important because toltrazuril is not FDA-approved for cattle.

Toltrazuril is generally considered well tolerated when used correctly, but any calf receiving it should still be monitored. The biggest practical concern is often not a direct drug reaction. It is the underlying coccidiosis itself, which can continue to cause diarrhea, weakness, dehydration, and poor appetite even after treatment starts.

Possible medication-related concerns can include temporary digestive upset, reduced appetite, or stress from oral dosing. If a calf is already weak, depressed, or dehydrated, handling and drenching can add risk. Aspiration is also possible if any oral medication is given improperly.

See your vet immediately if you notice bloody diarrhea, severe straining, recumbency, marked dehydration, neurologic signs, or rapid decline. Merck notes that some calves with acute coccidiosis can develop severe systemic illness, and rare cases may show central nervous system signs with high mortality.

If your ox or calf seems worse after treatment, do not assume the drug failed. The animal may need fluids, nursing support, a different diagnosis worked up, or a herd-level management change to reduce reinfection pressure.

There are no widely emphasized, routine drug interactions for toltrazuril in standard cattle references, but that does not mean interaction risk is zero. Your vet still needs a full medication list, including dewormers, sulfonamides, medicated feeds, ionophores, supplements, and any compounded products.

The more important safety issue in cattle is often regulatory and residue interaction, not a classic pharmacology interaction. In food animals, every added drug changes the residue-avoidance plan. If an animal is lactating, close to slaughter, or part of a show or sale program, your vet may choose a different coccidiosis strategy to protect food safety and marketing timelines.

Tell your vet if the calf is receiving other diarrhea treatments, electrolyte products, anti-inflammatories, or antibiotics. That helps them build a complete plan and avoid masking a more serious disease process.

Also mention whether the animal is intended for meat, breeding, or milk production. That information can change whether toltrazuril is even a practical option in your situation.